Hunan Hansen Pharmaceutical Co (SZSE:002412) Total Liabilities : ¥353 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Hansen Pharmaceutical Co Total Liabilities?

Hunan Hansen Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥353 Mil.

Hunan Hansen Pharmaceutical Co's quarterly Total Liabilities declined from Sep. 2024 (¥351.41 Mil) to Dec. 2024 (¥343.85 Mil) but then increased from Dec. 2024 (¥343.85 Mil) to Mar. 2025 (¥352.81 Mil).

Hunan Hansen Pharmaceutical Co's annual Total Liabilities declined from Dec. 2022 (¥396.81 Mil) to Dec. 2023 (¥373.46 Mil) and declined from Dec. 2023 (¥373.46 Mil) to Dec. 2024 (¥343.85 Mil).

Hunan Hansen Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Hunan Hansen Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Hansen Pharmaceutical Co Total Liabilities Chart

Hunan Hansen Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

293.92

368.99

396.81

373.46

343.85

Hunan Hansen Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															362.72	375.64	351.41	343.85	352.81

Hunan Hansen Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hunan Hansen Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	318.316	+	(0	+	25.536
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	344

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2547.234	-	2203.382
	=	344

Hunan Hansen Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	327.633	+	(0	+	25.179
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	353

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	2546.114	-	2193.302
	=	353

Hunan Hansen Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hunan Hansen Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Hansen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Hansen Pharmaceutical Co Ltd (SZSE:002412) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Silver City Road, Long Ridge Industrial Park, Heshan District, Yiyang City, CHN, 413000

Website

http://www.hansenzy.com

Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.

Executives

Luo Yong Qing	Directors, executives
Liu Zheng Qing	Directors, executives
Liu Ling An	Director
Fu Jian Jun	Executives
Liu Na Xin	Independent director
Liu Hou Yao	Directors, Directors, and Executives
He San Xing	Directors, executives

Hunan Hansen Pharmaceutical Co Headlines

No Headlines